MEDS) publishes its Q3 2021 financial report

TRxADE Group (NASDAQ: MEDS),a healthcare IT company focused on digitizing the retail pharmacy experience by optimizing drug supply, prescription journey and patient engagement in the United States, released its financial figures for the third quarter 2021, period ending September 30, 2021. report includes 34.3% revenue increase over second quarter 2021. In addition, the company noted that TRxADE Health has added approximately 250 new registered members to the third quarter. quarter, with a total of registered members now reaching nearly 13,000, and Bonum Health announced the availability of prepaid digital telemedicine passes, which provide uninsured consumers with an innovative way to access vital health services. The company plans to host a conference call this afternoon at 5 p.m. ET to discuss the financial report; the call will include a question-and-answer section. To participate, US callers should dial 1-877-425-9470; international callers should dial 1-201-389-0878. All callers must use conference ID 13723384. The call will also be available via webcast. We saw a strong improvement in margin as our revenue base returned to core pharmaceutical trading platform TRxADE in the third quarter, with one-off sales of personal protective equipment recorded in 2020 declining. were driven by the initial onset of COVID. -19 pandemic, TRxADE Health President and CEO Suren Ajjarapu said in the press release. “Our nationwide presence continues to grow and we have relentlessly focused on exciting new ways to expand proportionate portfolio share within our vast and growing network of registered users, while enabling them to better serve their respected customers – end users – by further increasing their loyalty to their local retail pharmacy. Our telehealth subsidiary Bonum Health has continued to grow, establishing a foundation we believe we can build on for years to come. . . . In summary, we focus [on] new strategic partnerships to advance our core business while diversifying our revenue base and leveraging our existing strengths through Bonum Health. Overall, we believe we are building an incredibly compelling healthcare ecosystem, enabling consumers to access affordable healthcare while creating an exciting value proposition for our shareholders. “

To view the webcast, visit

To view the full press release, visit

About Trxade Group Inc.

Trxade Group is a healthcare IT company focused on digitizing the retail pharmacy experience by optimizing drug supply, prescription journey and patient engagement in the United States. The company operates the drug supply market TRxADE serving a total of over 12,950 members nationwide and promoting price transparency as well as the Bonum Health brand, offering patient-centered telehealth services. For more information about the company, please visit and

NOTICE TO INVESTORS: The latest news and updates relating to MEDS are available in the company press room at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements delivered in multiple languages, we’ve got the wire-quality delivery products you’ll need to make sure your next press release grabs the attention of your target audience and doesn’t let go. As our competitors seek to pay you hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all national outings. While other news services can provide a basic review of your release, InvestorWire helps you do the best you can with Improved press release.

At our competitors, the job is done the second your exit goes on the wire. Not with InvestorWire. We include follow-up coverage of each release taking advantage of the ever-growing audience for the 50+ brands who make up the InvestorBrandNetwork.

Make the most of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please review the full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever posted or republished: Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, California 90046
310.299.1717 Office
[email protected]

InvestorWire is part of InvestorBrandNetwork.

Source link

Comments are closed.